Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer
Clinical trial NCT06408038 · COMPLETED
Trial details
- NCT number
- NCT06408038
- Sponsor
- Institut Claudius Regaud
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-25
- Primary completion
- 2025-10-08
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.